Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from EXACT Therapeutics AS ( (DE:56F) ).
EXACT Therapeutics AS has announced that its Annual General Meeting will be held virtually on June 13, 2025. This meeting is significant as it provides stakeholders with insights into the company’s strategic direction and operational updates, potentially impacting its market positioning and investor relations.
More about EXACT Therapeutics AS
EXACT Therapeutics is a clinical-stage precision medicine company focused on utilizing ultrasound and microbubbles for targeted drug delivery in oncology. The company’s Acoustic Cluster Therapy (ACT®) offers a unique approach applicable to a wide range of therapeutic agents in oncology and other indications, including brain diseases. EXACT Therapeutics is publicly traded on Euronext Growth Oslo under the ticker EXTX.
Average Trading Volume: 16,602
Current Market Cap: NOK175.9M
See more data about 56F stock on TipRanks’ Stock Analysis page.